Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eli Lilly and Company
UMC Utrecht
Memorial Sloan Kettering Cancer Center
Hoffmann-La Roche
Institut National de la Santé Et de la Recherche Médicale, France
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Institut Bergonié
Actuate Therapeutics Inc.
Centre Leon Berard
Adaptimmune